Vaccination

Is Novavax, the latecomer COVID vaccine, worth the wait?

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax COVID-19 vaccine in mid-October soon after it was finally recommended in the United States. Like many people with autoimmune diseases, ...

Diseases, Conditions, Syndromes

Study finds increased risk of Guillain-Barré after COVID-19 infection

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue ...

page 3 from 32